Development of the LAQ-6: a questionnaire for assessing long-term asthma control.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42562345.
- Also identified by DOI 10.1016/j.jaip.2026.07.036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Existing asthma questionnaires rely on short recall periods and may not capture symptom burden across typical follow-up intervals. A brief instrument that summarizes longer-term asthma control may support risk stratification and remission-oriented care. To develop a brief questionnaire that assesses symptom burden over a 3-month recall period and evaluate its performance in identifying ACT-defined well-controlled asthma. Ninety adults with asthma completed our questionnaire, the 6-item Long-term Asthma Control Questionnaire (LAQ-6), and the Asthma Control Test (ACT) in an outpatient setting. Correlation and receiver operating characteristic curve (ROC) analyses were performed to evaluate associations with ACT-defined well-controlled status (ACT ≥20). Confirmed exacerbations and emergency visits over an approximately 6-month observation window were assessed using ROC analyses and prespecified cutoffs. The LAQ-6 strongly correlated with the ACT (r = 0.79, P < .001) and asthma-related quality of life assessed using mean Asthma Quality of Life Questionnaire scores (Spearman's rho = 0.763, P < .001). It achieved an area under the curve (AUC) of 0.83 in identifying ACT-defined well-controlled status (ACT ≥20) (95% confidence interval, 0.72-0.94). For 6-month outcomes, the LAQ-6 achieved higher AUCs than the ACT for exacerbations (0.866 vs. 0.816) and emergency visits (0.857 vs. 0.676). Exacerbations and emergency visits were more frequent in patients with LAQ-6 scores below the prespecified cutoff (<27). The LAQ-6 is a brief 3-month recall questionnaire complementing existing short-recall tools. It may facilitate rapid assessment of longer-term symptom burden and risk stratification in outpatient practice, supporting evaluation of clinical remission.